Advertisement
Canada markets open in 1 hour 15 minutes
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7266
    +0.0003 (+0.04%)
     
  • CRUDE OIL

    82.06
    -0.67 (-0.81%)
     
  • Bitcoin CAD

    89,586.36
    +3,545.84 (+4.12%)
     
  • CMC Crypto 200

    1,336.58
    +23.96 (+1.86%)
     
  • GOLD FUTURES

    2,392.00
    -6.00 (-0.25%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,494.00
    -53.25 (-0.30%)
     
  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     
  • FTSE

    7,839.15
    -37.90 (-0.48%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6816
    -0.0005 (-0.07%)
     

Sanofi’s Kevzara Could Be Solid Addition to Rheumatoid Arthritis

Launched in US markets in June 2017, Kevzara (sarilumab), Sanofi (SNY) and Regeneron’s (REGN) IL-6 receptor antibody, has received favorable feedback from the physician community.